Abstract
Background and aims: Atrial fibrillation (AF) is the most common arrhythmia in elderly people, who are particularly exposed to its most severe complications, such as stroke, worsening heart failure and dementia. Some studies demonstrate that AF is associated with increased mortality in home-dwelling subjects, but little is known about the clinical impact of the arrhythmia in hospitalized patients. We studied the clinical associations and effects of AF on the 23,174 hospitalized patients enrolled in the GIFA (Gruppo Italiano di Farmacoepidemiologia nell’Anziano) Study. Methods: Patients were divided into three groups according to the absence or presence of AF (sinus rhythm, non_AF; AF as main diagnosis, AF_main; AF as comorbid condition, AF_associated) and stratified into four age-groups (≤60, 61–70, 71–80 and >80 yrs). Results: AF_associated patients were older, more frequently disabled, and characterized by greater comorbidity and longer in-hospital length of stay. Urea nitrogen concentration was higher, and total cholesterol was lower in AF_associated patients, compared with the other two groups. Overall mortality was 6.0%. Mortality was higher in AF_associated patients (non_AF: 6.0% vs AF_associated: 7.1% vs AF_main: 0%, p<0.001). Conclusions: Our results suggest that, in hospitalized patients, AF as a comorbid condition is associated with worse metabolic profile and clinical outcomes, and thus, may represent a marker of frailty.
Similar content being viewed by others
References
Lloyd-Jones D, Adams R, Carnethon M et al. Heart Disease and Stroke Statistics — 2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21–181.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–8.
Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257–354.
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695–703.
Miyasaka Y, Barnes ME, Petersen RC et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007; 28: 1962–7.
Benjamin EJ, Wolf PA, Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946–52.
Miyasaka Y, Barnes ME, Bailey KR et al. Mortality trends in patients diagnosed with first atrial fibrillation — a 21-year community-based study. J Am Coll Cardiol 2007; 49: 986–92.
Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093–9.
Carosella L, Pahor M, Pedone C, Zuccalà G, Manto A, Carbonin P. Pharmacosurveillance in hospitalized patients in Italy. Study design of the ‘Gruppo Italiano di Farmacovigilanza nell’Anziano’ (GIFA). Pharmacol Res 1999; 40: 287–95.
Zuccalà G, Onder G, Pedone C et al. Hypotension and cognitive impairment: Selective association in patients with heart failure. Neurology 2001; 57: 1986–92.
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914–9.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179–86.
Bergman H, Ferrucci L, Guralnik J et al. Frailty: An Emerging Research and Clinical Paradigm Issues and Controversies. J Gerontol A Biol Sci Med Sci 2007; 62: 731–7.
Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006; 9: 348–56.
Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119–25.
Chung MK, Martin DO, Sprecher D et al. C-Reactive Protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886–91.
Lip GYH, Patel JV, Hughes E, Hart RG. High-sensitivity C-Reactive Protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 2007; 38: 1229–37.
Ferrucd L, Turchi A, Fumagalli S et al. Sex-related differences in the length of disability prior to death in older persons. Aging Clin Exp Res 2003; 15: 310–4.
Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115: 2689–96.
Fumagalli S, Bondnelli L, Bondi E et al. Does advanced age affed the immediate and long-term results of direct-current external cardioversion of atrial fibrillation? J Am Geriatr Soc 2002; 50: 1192–7.
Mittal S, Ayati S, Stein KM et al. Transthoradc cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101: 1282–7.
O’Neill MD, Jais P, Hocini M et al. Catheter ablation for atrial fibrillation. Circulation 2007; 116: 1515–23.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Fumagalli, S., Tarantini, F., Guarducci, L. et al. Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA Study. Aging Clin Exp Res 22, 129–133 (2010). https://doi.org/10.1007/BF03324785
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324785